Alan A Kotch

Alan A. Kotch serves as a Contract Specialist responsible for managing the full lifecycle of federal acquisitions within a specialized technical domain. He ensures compliance with federal procurement regulations while executing competitive and compliant contracting actions to meet mission-critical needs. His portfolio is narrowly focused on the manufacturing of biological products, excluding diagnostic agents, requiring deep familiarity with cGMP, FDA regulatory alignment, and biopharmaceutical supply chain protocols. Kotch handles complex sole-source and sealed-bid procurements, often involving highly regulated, low-supplier environments where technical specificity and quality assurance are paramount. Kotch’s contractor relationships are characterized by engagement with a limited pool of specialized manufacturers capable of meeting stringent biological product standards. He works primarily with firms possessing validated production facilities, sterile processing capabilities, and established track records in GMP-compliant manufacturing. While no single contractor dominates his portfolio, his contracting patterns reflect consistent collaboration with a core group of qualified vendors who meet exacting technical and regulatory requirements. His approach emphasizes performance-based contracting and rigorous source selection criteria tailored to biological product integrity. Kotch’s procurement activity reflects a strong preference for open competition, with 100% of his acquisitions conducted without set-aside designations. This indicates a focus on technical capability and regulatory compliance over socioeconomic categorization, consistent with the limited number of qualified suppliers in the biological manufacturing space. While small business participation is not formally prioritized through 8(a), HUBZone, or SDVOSB set-asides, his process remains transparent and inclusive to all qualified offerors who meet the technical baseline. His primary NAICS code, 325414, defines his domain as the production of therapeutic biologics, vaccines, and other non-diagnostic biological substances. He procures complex, high-stakes items requiring cold chain logistics, aseptic processing, and batch traceability systems. Kotch brings specialized expertise in biopharmaceutical manufacturing regulations, ensuring acquisitions align with FDA oversight and public health imperatives.